Article
Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer.
BMC gastroenterology - 23 Nov 2017
Kim Dalyong, Kim Sun Young, Lee Ji Sung, Hong Yong Sang, Kim Jeong Eun, Kim Kyu-Pyo, Kim Jihun, Jang Se Jin, Yoon Young-Kwang, Kim Tae Won
Abstract excerpt
BACKGROUND: In metastatic colorectal cancer, the location of the primary tumor has been suggested to have biological significance. In this study, we investigated whether primary tumor location affects cetuximab efficacy in patients with RAS wild-type metastatic colorectal cancer. METHODS: Genotyping by the SequenomMassARRAY technology platform (OncoMap) targeting KRAS, NRAS, PIK3CA, and BRAF was performed in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
